Differences in the Insulin Resistance Levels Measured by HOMA-IR between Patients with Erosive and Non-Erosive Gastroesophageal Reflux Disease
Keywords:
insulin resistance, erosive esophagitis, esophageal erosion, HOMA-IRAbstract
Background. Insulin resistance is the core of Metabolic Syndrome which carries a high risk for cardiovascular events. Insulin resistance had been reported to be higher in GERD patients than subjects without GERD, specifically in erosive esophagitis.
Objective. To compare the degree of insulin resistance, using HOMA-IR index, between erosive and non-erosive reflux disease.
Methodology. A cross-sectional study of 84 adult patients with GERD symptoms was conducted. The subjects were recruited consecutively between January 2017 and April 2017 at Cipto Mangunkusumo National Hospital in Jakarta. Gastroesophageal Reflux Disease Questionnaire (GERDQ) was used for subject recruitment. Homeostatic model assessment-insulin resistance (HOMA-IR) index was used to evaluate insulin sensitivity. Esophageal erosions were diagnosed using upper gastrointestinal endoscopy. Bivariate analysis was used to determine HOMA-IR difference between esophagitis and non-esophagitis group.
Results. The median of HOMA-IR in all subjects was 1.46 (0.32-13.85). Mann-Whitney test revealed that HOMA-IR index was higher in patients with erosive esophagitis [median 1.74 (0.35-13.85)] than those without erosive esophagitis [median 1.21 (0.32-10.78)] (p=0.05).
Conclusion. Insulin resistance is significantly higher in gastroesophageal reflux disease patients with esophageal erosions than in those without esophageal erosion.
Downloads
References
Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19-39. PMCID: PMC1204764.
Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5-6):231-7. PMID: 19407331. PMCID: PMC2675814. https://doi.org/10.1242/dmm.001180.
Badan Penelitian dan Pengembangan Kesehatan RI. Riset Kesehatan Dasar (Riskesdas). Jakarta, 2013.
Soewondo P, Purnamasari D, Oemardi M, Waspadji S, Soegondo S. Prevalence of metabolic syndrome using NCEP/ATP III criteria in Jakarta, Indonesia: The Jakarta primary non-communicable disease risk factors surveillance 2006. Acta Med Indones.2010;42(4):199-203. PMID: 21063040.
Indonesian Society of Gastroenterology. National consensus on the management of gastroesophageal reflux disease in Indonesia. Acta Med Indones. 2014;46(3):263-71. PMID: 25348191.
Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014;5(3):105-112. PMCID: PMC4133436. https://doi.org/10.4292/wjgpt.v5.i3.105.
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28. PMID: 23419381. https://doi/org/10.1038/ajg.2012.444.
Pointer SD, Rickstrew J, Slaughter JC, Vaezi MF, Silver HJ. Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: A pilot study in European-and African-American obese women. Aliment Pharmacol Ther 2016;44(9):976–88. PMID: 27582035. PMCID: PMC5048546 [Available on 2017-11-01]. http://doi.org/10.1111/apt.13784.
Park JH, Park DI, Kim HJ, et al. Metabolic syndrome is associated with erosive esophagitis. World J Gastroenterol. 2008;14(35):5442-7. PMCID: PMC2744163. https://doi/org/10.3748/wjg.14.5442.
Fujiwara M, Eguchi Y, Fukumori N, et al. The symptoms of gastroesophageal reflux disease correlate with high body mass index, the aspartate aminotransferase/alanine aminotransferase ratio and insulin resistance in Japanese patients with non-alcoholic fatty liver disease. Intern Med. 2015;54(24):3099-104. PMID: 26666594. https://doi.org/10.2169/internalmedicine.54.4297.
Abdullah M, Makmun D, Syam AF, et al. Prevalence, risk factors and socio-epidemiological study of gastroesophageal reflux disease: An urban population based study in Indonesia. Asian J. Epidemiol. 2016;9(1-3):18-23. Available online: http://www.scialert.net/qredirect.php?doi=aje.2016.18.23&linkid=pdf.
Mungan Z. Prevalence and demographic determinants of gastroesophageal reflux disease (GERD) in the Turkish general population: A population-based cross-sectional study. Turk J Gastroenterol 2012;23(4):323-32. https://doi.org/10.4318/tjg.2012.0352.
Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44(6):518-34. PMID: 19365600. https://doi.org/10.1007/s00535-009-0047-5.
Çela L, Kraja B, Hoti K, et al. Lifestyle characteristics and gastroesophageal reflux disease: A population-based study in Albania. Gastroenterol Res Pract. 2013;2013: 93672. PMCID: PMC3595718. https://doi.org/10.1155/2013/936792.
Syam AF, Hapsari PFC, Makmun D. The prevalence and risk factors of GERD among Indonesian medical doctors. Makara J Health Res. 2016;20(2):35-40. https://doi.org/ 10.7454/msk.v20i2.5740.
Hsu CS, Wang PC, Chen JH, et al. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34(8):994-1004. PMID: 21848629. https://doi.org/ 10.1111/j.1365-2036.2011.04817.x.
Gado AS, Ebeid BA, Abdelmohsen AM, Axon A. Prevalence of reflux esophagitis among patients undergoing endoscopy in a secondary referral hospital in Giza, Egypt. AJM. 2015;51(2):89-94. https://doi.org/10.1016/j.ajme.2013.09.002.
Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: A systematic review. J Neurogastroenterol Motil. 2011;17(1):14-27. PMID: 21369488. PMCID: PMC3042214. https://doi.org/10.5056/jnm.2011.17.1.14.
Kamal M, Elbahrawy A, Monem MA, et al. Study of insulin resistance in patients with variable grades of gastroesophageal reflux diseases. Nature and Science. 2016;14(9):150-6. Available online: http://www.sciencepub.net/nature/ns140916/21_31173nsj140916_150_156.pdf.
Li CH, Hsieh TC, Hsiao TH, et al. Different risk factors between reflux symptoms and mucosal injury in gastroesophageal reflux disease. Kaohsiung J Med Sci. 2015;31(6):320-7. PMID: 26043412. https://doi.org/10.1016/j.kjms.2015.02.007.
Gosal F, Waleleng BJ, Pandelaki K. Hubungan kadar TNF α, nilai HOMA-IR dan pelemakan hati sederhana nonalkoholik pada pelajar SMA dengan obesitas. J Indon Med Assoc. 2013; 63(1):27-31.
Nasution IR, Setiati S, Trisnohadi HB, Oemardi M. Insulin resistance and metabolic syndrome in elderly women living in nursing homes. Acta Med Indones. 2006;38(1):17-22. PMID: 16479027.
Esteghamati A, Ashraf H, Khalilzadeh O, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: Third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutri Metab (London). 2010;7:26. PMID: 20374655. PMCID: PMC2857836. https://doi.org/10.1186/1743-7075-7-26.
Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut off values and the metabolic syndrome in a general adult population: Effect of gender and age: EPIRCE cross sectional study. BMC Endocr Disord. 2013;13:47. PMID: 24131857. PMCID: PMC4016563. https://doi.org/ 10.1186/1472-6823-13-47.
Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-95. PMID: 15161807.
Tai CM, Lee YC, Tu HP, et al. The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese Chinese patients. Obesity. 2010;18(11): 2165–9. https://doi.org/ 10.1038/oby.2010.143.
Saragih RH, Rey I. FSSG scale system in comparison with GERD questionnaires in predicting endoscopic findings with reflux esophagitis. INA-JGHE. 2012;14(3):136-40.
Rieder F, Biancani P, Hatnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: Impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2010;298(5):G571–81. PMCID: PMC2867418. https://doi.org/10.1152/ajpgi.00454.2009.
Nam SY, Choi IJ, Ryu KH, et al. The effect of abdominal visceral fat, circulating inflammatory cytokines and leptin levels on reflux esophagitis. J Neurogastroenterol Motil. 2015;21(2):247-52. PMCID: PMC4398239. https://doi.org/10.5056/jnm14114.
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793-1801. PMID: 16823477. PMCID: PMC1483173. https://doi.org/10.1172/JCI29069.
Porwal NB, Ghildiyal A, Singh S, et al. Circulating interleukins (IL6)-An early predictor of insulin resistance. AJMS. 2016;7(6):20-5. https://doi.org/10.3126/ajms.v7i6.15250.
Chen J, Wildman RP, Hamm L, et al. Association between inflammation and insulin resistance in U.S. nondiabetic adults. Diabetes Care. 2004; 27(12):2960–5. PMID: 15562214.
Fujikawa Y, Tominaga K, Fujii H, et al. High prevalence of gastroesophageal reflux symptoms in patients with non-alcoholic fatty liver disease associated with serum levels of triglyceride and cholesterol but not simple visceral obesity. Digestion. 2012;86(3):228–37. PMID: 22964626. https://doi.org/10.1159/000341418.
Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007:116(1):39-46. PMID: 17576866. https://doi.org/10.1161/CIRCULATIONAHA.106.675355.
Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes. 2008;57(5):1269-74.
PMID: 18299316. https;//doi.org/10.2337/db07-1378.
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.
